The plasma level of RBP4 in patients with breast cancer was significantly higher in specimens from metastatic cancers (lymph nodes or disseminated metastases) than those in healthy volunteers and patients without diagnosed metastases (Figure 3C). Here, RBP4 is linked to breast cancer.